Skip to main content
Premium Trial:

Request an Annual Quote

Tm Extends Alliance With Luminex to Sell Dx Products On xMAP Platform

NEW YORK, March 29 (GenomeWeb News) - Tm Bioscience has extended for  multiple additional years an agreement with Luminex to sell DNA-based molecular diagnostics that operate on Luminex's xMAP platform, Tm said today.

 

All of Tm's genetic tests use its Tag-It Universal Array platform. Tm's assays, meantime, use Luminex's xMAP platform.

 

The original agreement between the two companies, launched in 2001, expired yesterday. The renegotiated deal incorporates "similar terms" to the original, including the ability for Tm to distribute such xMAP systems as the new LX200 instrument, Tm said.


Financial terms of the deal were not disclosed.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.